BenzingaNowIonis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challengesbenzinga.com - Vandana SinghIonis Pharmaceuticals Inc (NASDAQ: IONS) entered an agreement with Roche Holdings AG (OTC: RHHBY) for two undisclosed early-stage programs for …
BenzingaNowSeelos Therapeutics' Aggressive Alzheimer's Hopeful Candidate Shows Encouraging Preclinical Activitybenzinga.com - Vandana SinghSeelos Therapeutics Inc (NASDAQ: SEEL) announced preclinical data from an in vivo study of SLS-005 (trehalose injection, 90.5 mg/mL for intravenous …
BenzingaNowWhat's Going On Pfizer's Subsidiary Biohaven Stock?benzinga.com - Vandana SinghPfizer Inc's (NYSE: PFE) subsidiary Biohaven Ltd (NYSE: BHVN) released an read moreThis article What's Going On Pfizer's Subsidiary Biohaven Stock? …
Benzinga1 hour agoGuardant Health Has 'Underlying Business Strength' Says This Bullish Analystbenzinga.com - Priya NigamShares of Guardant Health Inc (NASDAQ: GH) climbed during the premarket trading session and morning on Wednesday.Proprietary industry checks suggested …
Benzinga1 hour agoPopular Weight Loss Drugs Ozempic and Wegovy Alert: FDA Adds Intestinal Blockage Warningbenzinga.com - Vandana SinghIn a significant development, the FDA has updated the labeling for Novo Nordisk A/S's (NYSE: NVO) Ozempic, a diabetes drug known for its weight loss …
Benzinga1 hour agoBiden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugsbenzinga.com - Vandana SinghU.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a …
